Therefore, pro-inflammatory cytokines, such as TNF-α, IL-6, and IL-1β, and TJ proteins such as ZO-1 and occludin, are important targets in IBD treatment and in regulating intestinal barrier function [7,34]. This evidence concerns the gene IL1B and inflammatory bowel disease.